SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-19-031177
Filing Date
2019-06-17
Accepted
2019-06-17 16:28:49
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tv523373_s3.htm S-3 214469
2 EXHIBIT 5.1 tv523373_ex5-1.htm EX-5.1 17073
3 EXHIBIT 23.1 tv523373_ex23-1.htm EX-23.1 2491
4 GRAPHIC tv523373_ex5-1img01.jpg GRAPHIC 7761
5 GRAPHIC tv523373_ex5-1img02.jpg GRAPHIC 5605
6 GRAPHIC tv523373_s3img01.jpg GRAPHIC 10429
  Complete submission text file 0001144204-19-031177.txt   268325
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-232163 | Film No.: 19901689
SIC: 8731 Services-Commercial Physical & Biological Research